Venographic classification and long-term surgical treatment outcomes for axillary-subclavian vein thrombosis due to venous thoracic outlet syndrome (Paget-Schroetter syndrome)
Journal of Vascular Surgery · 2023-03 · 77 (3) · 879-889.e3
DOI: 10.1016/j.jvs.2022.11.053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2023-03. Verfasst von Esmaeel Reza Dadashzadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Thoracic Outlet Syndrome, Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Upper Extremity Deep Vein Thrombosis, Venous Thrombosis, Thoracic Outlet Syndrome, Vascular Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Barnes-Jewish Hospital.
Abstract (Originalsprache)
OBJECTIVE: We assessed the clinical presentation, operative findings, and surgical treatment outcomes for axillary-subclavian vein (AxSCV) thrombosis due to venous thoracic outlet syndrome (VTOS). METHODS: We performed a retrospective, single-center review of 266 patients who had undergone primary surgical treatment of VTOS between 2016 and 2022. The clinical outcomes were compared between the patients in four treatment groups determined by intraoperative venography. RESULTS: Of the 266 patients, 132 were male and 134 were female. All patients had a history of spontaneous arm swelling and idiopathic AxSCV thrombosis, including 25 (9%) with proven pulmonary embolism, at a mean age of 32.1 ± 0.8 years (range, 12-66 years). The timing of clinical presentation was acute ( 90 days) for 63 patients (24%). Venography with catheter-directed thrombolysis or thrombectomy (CDT) and/or balloon angioplasty had been performed in 188 patients (71%). The median interval between symptom onset and surgery was 78 days. After paraclavicular thoracic outlet decompression and external venolysis, intraoperative venography showed a widely patent AxSCV in 150 patients (56%). However, 26 (10%) had a long chronic AxSCV occlusion with axillary vein inflow insufficient for bypass reconstruction. Patch angioplasty was performed for focal AxSCV stenosis in 55 patients (21%) and bypass graft reconstruction for segmental AxSCV occlusion in 35 (13%). The patients who underwent external venolysis alone (patent or occluded AxSCV; n = 176) had a shorter mean operative time, shorter postoperative length of stay and fewer reoperations and late reinterventions compared with those who underwent AxSCV reconstruction (patch or bypass; n = 90), with no differences in the incidence of overall complications or 30-day readmissions. At a median clinical follow-up of 38.7 months, 246 patients (93%) had no arm swelling, and only 17 (6%) were receiving anticoagulation treatment; 95% of those with a patent AxSCV at the end of surgery were free of arm swelling vs 69% of those with a long chronic AxSCV occlusion (P 90% of all patients with VTOS. Further work is needed to achieve earlier recognition of AxSCV thrombosis, prompt usage of CDT, and even more effective surgical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Thoracic Outlet Syndrome, Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO.
- Section of Vascular Interventional Radiology, Department of Radiology, Washington University School of Medicine, St. Louis, MO.
- Center for Thoracic Outlet Syndrome, Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO; Section of Vascular Interventional Radiology, Department of Radiology, Wa…
Förderung
- Foundation for Barnes-Jewish Hospital
Zitieren
APA
Dadashzadeh, E. R., Ohman, J. W., Kavali, P. K., Henderson, K. M., Goestenkors, D. M., & Thompson, R. W. (2023). Venographic classification and long-term surgical treatment outcomes for axillary-subclavian vein thrombosis due to venous thoracic outlet syndrome (Paget-Schroetter syndrome). Journal of Vascular Surgery, 77(3), 879-889.e3. https://doi.org/10.1016/j.jvs.2022.11.053
Vancouver
Dadashzadeh ER, Ohman JW, Kavali PK, Henderson KM, Goestenkors DM, Thompson RW. Venographic classification and long-term surgical treatment outcomes for axillary-subclavian vein thrombosis due to venous thoracic outlet syndrome (Paget-Schroetter syndrome). Journal of Vascular Surgery. 2023;77(3):879-889.e3. doi:10.1016/j.jvs.2022.11.053
BibTeX
@article{Dadashzadeh2023,
author = {Dadashzadeh, Esmaeel Reza and Ohman, J Westley and Kavali, Pavan K and Henderson, Karen M and Goestenkors, Danita M and Thompson, Robert W},
title = {Venographic classification and long-term surgical treatment outcomes for axillary-subclavian vein thrombosis due to venous thoracic outlet syndrome (Paget-Schroetter syndrome)},
journal = {Journal of Vascular Surgery},
year = {2023},
volume = {77},
number = {3},
pages = {879--889.e3},
doi = {10.1016/j.jvs.2022.11.053}
}
EUVIMED